StockData
ResMed Inc logo

ResMed Inc (RMD) company profile

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3014% below fair value
$237.85−0.34 (-0.14%)

Close on Nov 17, 2026Market cap $33.46BP/E 21.7Yield 1.01%

About ResMed

Surgical & Medical Instruments & Apparatus, SIC 3841

ResMed Inc. develops digital health solutions, cloud-connected medical devices, and care management software platforms. The company operates through two business segments: Sleep and Breathing Health, and Residential Care Software. Its core offering includes continuous positive airway pressure systems, bilevel and adaptive servo-ventilation equipment, ventilators, diagnostic products, mask systems, and cloud applications like AirView and myAir. In addition, it provides residential care management platforms, including Brightree and MEDIFOX DAN. Its solutions serve individuals with sleep apnea and respiratory conditions, alongside clinicians, durable medical equipment suppliers, and residential healthcare organizations.

The company conducts commercial operations globally, distributing products across more than 140 countries through wholly owned operating subsidiaries and independent distributors, supported by approximately 11,370 employees worldwide. ResMed Inc. was incorporated under Delaware law as the ultimate holding company for its operating subsidiaries, while the provided text does not state a specific city or physical headquarters location.

Summary of the business section of ResMed's latest annual report, written by StockData.

Company profile

Company

Legal name
ResMed Inc
Founded
1989
Headquarters
San Diego, CA
Address
9001 Spectrum Center Blvd. 92123
Phone
(858) 746-2400
Website
resmed.com
Employees
11,370, Jun 30, 2026
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
June 30
Auditor
KPMG LLP, San Diego, CA

Stock & identifiers

Ticker
RMD
Other tickers
RSMDF
Exchange
NYSE
IPO date
Jun 2, 1995
Shares outstanding
141M, Oct 26, 2026
Public float
$34.92B, Dec 31, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, Aug 31, 2010; 2-for-1, Oct 3, 2005; 2-for-1, Apr 3, 2000; 2-for-1, Nov 17, 1998
SEC CIK
943819
CUSIP
761152107
ISIN
US7611521078
FIGI
BBG000L4M7F1
Share class FIGI
BBG001SBGRC2
LEI
529900T3QE5253CCXF22
EIN
98-0152841

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Michael J. FarrellChairman and CEO, Director473,864
Aaron BloomerChief Financial Officer7,977
Michael J. RiderGlobal General Counsel10,417
Justin LeongChief Product Officer35,489
Brett SandercockChief Financial Officer83,495
Kaushik GhoshalChief Commercial Officer, SaaS19,430
Witte Jan DeDirector4,201
Peter C. FarrellDirector1,095,808
Harjit GillDirector10,904
Nicole Mowad-NassarDirector777
Christopher DelOreficeDirector2,423
Carol BurtDirector18,816
John HernandezDirector5,118
Desney TanDirector6,002
Ronald R. TaylorDirector24,771
Karen DrexlerDirector10,602
Richard SulpizioDirector17,796

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2026$16.20M-$6.80M$3.58M$79$82
FY2025$14.67M$29.63M$3.36M$105$104
FY2024$14.12M$10.33M$3.13M$78$93
FY2023$13.87M$16.87M$4.15M$89$94
FY2022$11.66M$4.37M$3.63M$85$84
FY2021$10.39M$32.80M$4.17M$128$135

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2026

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsOption awardsIncentive payOtherTotalvs. prior year
Michael Farrell
Chief executive officer
$1.27M$9.75M$3.25M$1.74M$190.52K$16.20M+10%
Aaron Bloomer
Chief financial officer
$114.55K$3.30M–$92.73K$8.96K$3.52M–
Justin Leong
Chief product officer
$752.93K$3.10M–$609.51K$94.85K$4.56M+17%
Michael Rider
Global general counsel and secretary
$535.41K$1.55M–$325.07K$55.02K$2.47M+8%
Brett Sandercock
Former chief financial officer and special advisor to CEO
$600.16K$2.60M–$485.85K$82.48K$3.77M+5%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of June 30, 2026, we had approximately 11,370 employees, of which approximately 4,590 were employed in cost of sales activities including areas such as warehousing and manufacturing, 2,300 in research and development and 4,480 in sales, marketing and administration.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?